Key Metrics
2.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
44
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q3
Pharmacology
SJR
- Q3 Pharmacology
- Q3 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.82
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
11%
4 to 6 months
54%
7 to 9 months
32%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Quality of life
- Gas chromatography
- Body mass index
- Adult patients
- Tumor burden
- Prostate cancer
- Evidence-based practice
- Intranasal Ketamine
- Primary osteoporosis
- Systematic review
- Droplet size
- Constipation
- Carissa carandas
- Simvastatin
- Castration Resistance
- Placebo
- Salbutamol
- Safety profile
- Zoledronic acid therapy
- Molecular Docking Analysis
Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | USD 2000 |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 1959 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 12 |
| Article Processing Charges | USD 2000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Double anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Current Therapeutic Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Innovative Solutions for Multidrug-resistant Organisms Infections in ICU: A Joint Efficacy Evaluation of Multi-disciplinary Team and SHEL Model (Software, Hardware, Environment, Liveware)
- 1 Dec 24
- Current Therapeutic Research
-
Full paper
Impact of Dipeptidyl Peptidase-4 Inhibitors on Aminotransferases Levels in Patients with Type 2 Diabetes Mellitus with Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trial
- 1 Dec 24
- Current Therapeutic Research
-
Full paper
Oral cyclosporine treatment for four pediatric patients with toxic epidermal necrolysis that showed no response to high-dose corticosteroids in combination with intravenous immunoglobulin: A Case series
- 1 Dec 24
- Current Therapeutic Research
-
Full paper
Alpha-lipoic acid-mediated inhibition of LTB4 synthesis suppresses epithelial-mesenchymal transition, modulating functional and tumorigenic capacities in non-small cell lung cancer A549 cells
- 1 Nov 24
- Current Therapeutic Research
-
Full paper
Clinical Performance and Safety of Cerviron® Vaginal Ovules in the Management of Symptomatic Cervical Lesions: A National, Multicentric Study
- 1 Oct 24
- Current Therapeutic Research
-
Full paper
A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis
- 12 Sep 24
- Current Therapeutic Research
Scite analysis
Powered by scite_
2.2k articles received 12.4k citations see all
- 643 Supporting
- 11,183 Mentioning
- 107 Contrasting
Editorial notices
- 2 Retractions
- 2 Withdrawals
- 0 Corrections
- 6 Errata
- 0 Expression of Concern
FAQs
How long has Current Therapeutic Research been actively publishing?
Current Therapeutic Research has been in operation since 1959 till date.
What is the publishing frequency of Current Therapeutic Research ?
Current Therapeutic Research published with a Semi-annual frequency.
How many articles did Current Therapeutic Research publish last years ?
In 2023, Current Therapeutic Research published 37 articles.
What is the eISSN & pISSN for Current Therapeutic Research ?
For Current Therapeutic Research,eISSN is 1879-0313 and pISSN is0011-393X.
What is Citescore for Current Therapeutic Research ?
Citescore for Current Therapeutic Research is 2.5.
What is H index for Current Therapeutic Research ?
H index for Current Therapeutic Research is 44.
What is SNIP score for Current Therapeutic Research ?
SNIP score for Current Therapeutic Research is 0.82.
What is the SJR for Current Therapeutic Research ?
SJR for Current Therapeutic Research is Q3.
Who is the publisher of Current Therapeutic Research ?
ELSEVIER SCIENCE INC is the publisher of Current Therapeutic Research.